These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12106850)

  • 1. Short-term effect of atorvastatin (80 mg) on plasma lipids of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction.
    Correia LC; Spósito AC; Passos LC; Lima JC; Braga JC; Rocha MS; Esteves JP; D'Oliveira A
    Am J Cardiol; 2002 Jul; 90(2):162-4. PubMed ID: 12106850
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction.
    Colivicchi F; Guido V; Tubaro M; Ammirati F; Montefoschi N; Varveri A; Santini M
    Am J Cardiol; 2002 Oct; 90(8):872-4. PubMed ID: 12372577
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of atorvastatin (80 mg) on recurrent ischemia in unstable angina pectoris or non-ST-elevation acute myocardial infarction.
    Correia LC; Magalhães LP; Santana O; Rocha MS; Passos LC; D'Oliveira A; Esteves JP; Spósito AC
    Am J Cardiol; 2003 Jun; 91(11):1355-7. PubMed ID: 12767434
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction.
    Correia LC; Spósito AC; Lima JC; Magalhães LP; Passos LC; Rocha MS; D'Oliveira A; Esteves JP
    Am J Cardiol; 2003 Aug; 92(3):298-301. PubMed ID: 12888137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Miller M
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309746
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid-lowering therapy in acute coronary syndromes.
    Sacks FM
    JAMA; 2001 Apr; 285(13):1758-60. PubMed ID: 11277832
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
    Ghali JK
    Am J Cardiol; 1998 Sep; 82(5):703. PubMed ID: 9732912
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy.
    Waters DD; Schwartz GG; Olsson AG; Zeiher A; Oliver MF; Ganz P; Ezekowitz M; Chaitman BR; Leslie SJ; Stern T;
    Circulation; 2002 Sep; 106(13):1690-5. PubMed ID: 12270864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Sasiela WJ; Szarek M; Ganz P; Libby P;
    Circulation; 2004 Jul; 110(4):386-91. PubMed ID: 15262833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Gotto AM
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309745
    [No Abstract]   [Full Text] [Related]  

  • 11. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Auer J; Weber T; Eber B
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309747
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level.
    Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Kotsopoulou M; Tsioufis C; Stefanadis C
    Int J Cardiol; 2006 Apr; 109(1):48-52. PubMed ID: 16002160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statin therapy in patients with acute coronary syndrome. "Prove-it" study].
    von Schacky C
    Internist (Berl); 2004 Dec; 45(12):1437-9. PubMed ID: 15448925
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
    Schwartz GG; Oliver MF; Ezekowitz MD; Ganz P; Waters D; Kane JP; Texter M; Pressler ML; Black D; Chaitman BR; Olsson AG
    Am J Cardiol; 1998 Mar; 81(5):578-81. PubMed ID: 9514453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Paradis JM; LeLorier J
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309744
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
    Gómez-Gerique JA; Casciano R; Stern L; Rejas J
    Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Cannon CP; Braunwald E; McCabe CH; Rader DJ; Rouleau JL; Belder R; Joyal SV; Hill KA; Pfeffer MA; Skene AM;
    N Engl J Med; 2004 Apr; 350(15):1495-504. PubMed ID: 15007110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction.
    Teshima Y; Yufu K; Akioka H; Iwao T; Anan F; Nakagawa M; Yonemochi H; Takahashi N; Hara M; Saikawa T
    J Cardiol; 2009 Feb; 53(1):58-64. PubMed ID: 19167639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?
    Waters DD; Hsue PY
    Am J Cardiol; 2001 Oct; 88(7B):7J-16J. PubMed ID: 11595193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.